- Home
- ASND vs SIRI Comparison
ASND vs SIRI Comparison
Compare ASND & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- SIRI
- Stock Information
- Founded
- ASND 2006
- SIRI 2013
- Country
- ASND Denmark
- SIRI United States
- Employees
- ASND N/A
- SIRI N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- SIRI Broadcasting
- Sector
- ASND Health Care
- SIRI Consumer Discretionary
- Exchange
- ASND Nasdaq
- SIRI Nasdaq
- Market Cap
- ASND 10.6B
- SIRI N/A
- IPO Year
- ASND 2015
- SIRI 1994
- Fundamental
- Price
- ASND $170.86
- SIRI $22.51
- Analyst Decision
- ASND Strong Buy
- SIRI Hold
- Analyst Count
- ASND 16
- SIRI 14
- Target Price
- ASND $218.19
- SIRI $26.50
- AVG Volume (30 Days)
- ASND 435.4K
- SIRI 3.1M
- Earning Date
- ASND 05-01-2025
- SIRI 07-31-2025
- Dividend Yield
- ASND N/A
- SIRI 4.70%
- EPS Growth
- ASND N/A
- SIRI N/A
- EPS
- ASND N/A
- SIRI N/A
- Revenue
- ASND $398,509,511.00
- SIRI $8,605,000,000.00
- Revenue This Year
- ASND $75.05
- SIRI N/A
- Revenue Next Year
- ASND $78.14
- SIRI N/A
- P/E Ratio
- ASND N/A
- SIRI N/A
- Revenue Growth
- ASND 12.06
- SIRI N/A
- 52 Week Low
- ASND $111.09
- SIRI $18.69
- 52 Week High
- ASND $183.00
- SIRI $41.60
- Technical
- Relative Strength Index (RSI)
- ASND 52.37
- SIRI 56.49
- Support Level
- ASND $166.84
- SIRI $21.32
- Resistance Level
- ASND $180.78
- SIRI $22.71
- Average True Range (ATR)
- ASND 5.57
- SIRI 0.62
- MACD
- ASND -0.53
- SIRI 0.06
- Stochastic Oscillator
- ASND 38.59
- SIRI 68.42
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.